R Zahn

Summary

Publications

  1. ncbi Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    EuroIntervention 4:524-8. 2009
  2. ncbi Carotid artery stenting: do procedural complications relate to the side intervened upon?: results from the Carotid Artery Stent (CAS)-Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)
    Ralf Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
    Catheter Cardiovasc Interv 74:1-8. 2009
  3. ncbi [Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only]
    Ralf Zahn
    Chefarzt der Medizinischen Klinik B, Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen
    Herz 34:211-7. 2009
  4. ncbi Transcatheter Aortic Valve Implantation in Patients With "Porcelain" Aorta (from a Multicenter Real World Registry)
    Ralf Zahn
    Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Ludwigshafen, Germany Electronic address
    Am J Cardiol 111:602-8. 2013
  5. ncbi Long-term follow-up after coronary stenting with the sirolimus-eluting stent in clinical practice: results from the prospective multi-center German Cypher Stent Registry
    Ralf Zahn
    Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
    Clin Res Cardiol 101:709-16. 2012
  6. ncbi Midventricular form of takotsubo cardiomyopathy as a recurrence 1 year after typical apical ballooning: a case report
    Oliver Koeth
    Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Cases J 1:331. 2008
  7. ncbi Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices?
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    J Am Coll Cardiol 45:1769-74. 2005
  8. ncbi Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry)
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    Am J Cardiol 95:1302-8. 2005
  9. ncbi Coronary stenting with the sirolimus-eluting stent in clinical practice: final results from the prospective multicenter German Cypher Stent Registry
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    J Interv Cardiol 23:18-25. 2010
  10. ncbi Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology
    Ralf Zahn
    Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Germany
    Clin Res Cardiol 99:193-7. 2010

Collaborators

Detail Information

Publications87

  1. ncbi Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    EuroIntervention 4:524-8. 2009
    ..We sought to determine the efficacy of enoxaparin in unselected patients with STEMI treated with primary percutaneous coronary intervention in clinical practice...
  2. ncbi Carotid artery stenting: do procedural complications relate to the side intervened upon?: results from the Carotid Artery Stent (CAS)-Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)
    Ralf Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
    Catheter Cardiovasc Interv 74:1-8. 2009
    ..To determine the influence of the side intervened upon on outcomes during carotid artery stenting (CAS)...
  3. ncbi [Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only]
    Ralf Zahn
    Chefarzt der Medizinischen Klinik B, Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen
    Herz 34:211-7. 2009
    ..However, at least in regions with a high density of invasive centers, such networks should take the investigators' experience and the annual interventional volumes of the participating hospitals into account...
  4. ncbi Transcatheter Aortic Valve Implantation in Patients With "Porcelain" Aorta (from a Multicenter Real World Registry)
    Ralf Zahn
    Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Ludwigshafen, Germany Electronic address
    Am J Cardiol 111:602-8. 2013
    ..Although differences were found in its frequency among the participating hospitals, the presence of a porcelain aorta was not associated with in-hospital death or stroke...
  5. ncbi Long-term follow-up after coronary stenting with the sirolimus-eluting stent in clinical practice: results from the prospective multi-center German Cypher Stent Registry
    Ralf Zahn
    Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
    Clin Res Cardiol 101:709-16. 2012
    ..To obtain long-term follow-up data of the sirolimus-eluting coronary stent (SES) and to determine factors associated with clinical events and target vessel revascularization (TVR)...
  6. ncbi Midventricular form of takotsubo cardiomyopathy as a recurrence 1 year after typical apical ballooning: a case report
    Oliver Koeth
    Herzzentrum Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Cases J 1:331. 2008
    ..Recurrences of Takotsubo Cardiomyopathy, especially in variant regions of the left ventricle are rareWe describe a midventricular form of Takotsubo Cardiomyopathy as a recurrence 1 year after typical apical ballooning...
  7. ncbi Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices?
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    J Am Coll Cardiol 45:1769-74. 2005
    ..We sought to compare the efficacy of a filter embolic protection device (F-EPD) and a distal occlusive embolic protection device (DO-EPD) in patients undergoing carotid artery stenting (CAS)...
  8. ncbi Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry)
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    Am J Cardiol 95:1302-8. 2005
    ..The management of bypass grafts and multiple lesions in 1 session and the presence of multivessel disease were predictors of MACCEs or TVR...
  9. ncbi Coronary stenting with the sirolimus-eluting stent in clinical practice: final results from the prospective multicenter German Cypher Stent Registry
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    J Interv Cardiol 23:18-25. 2010
    ..However, because of safety concerns and frequent "off-label" use data from "real life," registries are necessary to monitor indications and outcome of DES in daily clinical practice...
  10. ncbi Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology
    Ralf Zahn
    Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Germany
    Clin Res Cardiol 99:193-7. 2010
    ..Concerning this pathophysiology, a further TAVI was performed using a second 29-mm CoreValve Revalving system, as a "valve-in-valve" implantation...
  11. ncbi Carotid artery stenting in clinical practice results from the Carotid Artery Stenting (CAS)-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 94:163-72. 2005
    ..However, its feasibility and safety in clinical practice at a broad spectrum of hospitals needs to be determined...
  12. ncbi Carotid artery interventions for restenosis after prior stenting: is it different from interventions of de novo lesions? Results from the carotid artery stent (CAS)--registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)
    Ralf Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstraße 79, 67063 Ludwigshafen, Germany
    Clin Res Cardiol 99:809-15. 2010
    ..To compare characteristics and outcome of patients with re-stenoses after prior carotid artery stenting (CAS) treated with repeat carotid interventions (Re-CI) with CAS for de novo lesions...
  13. ncbi Embolic protection devices for carotid artery stenting: better results than stenting without protection?
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    Eur Heart J 25:1550-8. 2004
    ..However, CAS itself can cause cerebral ischaemic events. Embolic protection devices (PD) promise to reduce the incidence of these events...
  14. ncbi [Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement]
    Ralf Zahn
    Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Ludwigshafen
    Dtsch Med Wochenschr 135:1589-95. 2010
    ....
  15. ncbi Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardio
    R Zahn
    Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg Süd, Nurnberg
    Heart 94:329-35. 2008
    ..The formerly observed volume-outcome relation for percutaneous coronary interventions (PCIs) has recently been questioned...
  16. ncbi Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry
    Ralf Zahn
    Klinikum Swfd, Kardiologie, Nurnberg, Germany
    Am Heart J 152:1146-52. 2006
    ....
  17. ncbi Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry
    Ralf Zahn
    Städtisches Klinikum, Med Klinik 8, Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg, 90471 Nürnberg, Germany
    Eur Heart J 28:370-5. 2007
    ..We tried to determine the influence of age on complication rates of carotid artery stenting (CAS)...
  18. ncbi The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry
    Ralf Zahn
    Med Klinik 8, Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg Süd, Breslauer Strasse 201, 90471, Nurnberg, Germany
    Clin Res Cardiol 96:548-56. 2007
    ..Due to limited budgets in Germany, no special reimbursement has been given for their use and therefore they were mainly used in selected patients...
  19. ncbi Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)
    R Zahn
    Kardiologie Angiologie Internistische Intensivmedizin, Klinikum Nürnberg, Breslauer Strasse 201, 90471 Nürnberg, Germany
    Clin Res Cardiol 96:730-7. 2007
    ..Glycoprotein II b/IIIa antagonists (GPII b/IIIa-A) lower the periprocedural rate of ischemic events during high risk percutaneous coronary interventions. Their clinical impact on carotid artery stenting (CAS) remains to be determined...
  20. ncbi Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry
    Ralf Zahn
    Med Klinik B, Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Clin Res Cardiol 99:99-106. 2010
    ..Treatment of restenosis following intracoronary brachytherapy (ICB) is still a challenging problem. Implantation of sirolimus-eluting stents (SES) in this setting may be an option to be evaluated...
  21. ncbi Survived heart arrest in a 24 year old woman: a late sequel of formerly undiagnosed Kawasaki disease
    Ralf Zahn
    Med. Klinik 8 Kardiologie/Angiologie/Internistische Intensivmedizin, , Breslauer Strasse 201, 90471, , Germany
    Clin Res Cardiol 95:316-8. 2006
  22. ncbi Reperfusion therapy for acute ST-elevation and non ST-elevation myocardial infarction: what can be achieved in daily clinical practice in unselected patients at an interventional center?
    Ralf Zahn
    Heart Center, Department of Cardiology, Ludwigshafen, Germany
    Acute Card Care 11:92-8. 2009
    ..The characterization of AMI patients according to this definition is still incomplete...
  23. ncbi An unusual cause of dyspnoea and pulmonary hypertension in a patient with a symptom history of 20 years--"Just do it again"
    Ralf Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Clin Res Cardiol 95:68-71. 2006
  24. ncbi Treatment of a large coronary saphenous bypass graft aneurysm by implantation of covered stents
    Ralf Zahn
    Med. Klinik 8, Kardiologie/Angiologie/Internistische Intensivmedizin, , Breslauer Strasse 201, 90471, , Germany
    Clin Res Cardiol 95:313-5. 2006
  25. ncbi Stent-supported angioplasty versus endarterectomy for carotid artery stenosis: evidence from current randomized trials
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstr 79, 67063, Ludwigshafen, Germany
    Z Kardiol 94:836-43. 2005
    ..However, the value of CAS is still a matter of debate. Therefore, we performed a metaanalysis of the randomized controlled clinical trials (RCT) on this issue...
  26. ncbi In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbe
    R Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Germany
    Heart 91:1041-6. 2005
    ..To determine the predictors of time between presentation and primary angioplasty and the influence of this delay time on in-hospital mortality in clinical practice...
  27. ncbi [Cypher stent: the German registry. Results of the German prospective multicenter registry on Cypher]
    R Zahn
    Herzzentrum, Kardiologie, Ludwigshafen, Allemagne
    Ann Cardiol Angeiol (Paris) 53:36s-39s. 2004
  28. ncbi "Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 93:287-94. 2004
    ..Therefore, actual clinical practice may be very different to RCT...
  29. ncbi Small differences in non-fatal in-hospital reinfarctions complicating acute myocardial infarction as observed in current randomised controlled trials will not essentially influence long-term mortality. Results from the Maximal Individual Therapy in Acute
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 92:847-51. 2003
    ....
  30. ncbi Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Germany
    Am Heart J 142:105-11. 2001
    ..In patients with acute myocardial infarction treated with thrombolysis, longer times to treatment are associated with increasingly worse clinical outcome. This relation may be different for treatment with primary angioplasty...
  31. ncbi Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction
    R Zahn
    Department of Cardiology, Herzzentrum Ludwigshafen, Germany
    J Am Coll Cardiol 37:1827-35. 2001
    ..We sought to determine the effectiveness of primary angioplasty compared with thrombolysis in clinical practice...
  32. ncbi Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and th
    R Zahn
    Herzzentrum Ludwigshafen, Dept of Cardiology, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    J Invasive Cardiol 13:367-72. 2001
    ..There are no data addressing whether this time limit is also justified for treatment with primary angioplasty...
  33. ncbi [Interventional therapy of acute myocardial infarction]
    R Zahn
    Kardiologie, Pneumologie, Angiologie und Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
    Internist (Berl) 49:1038-46. 2008
    ..In Germany this goal is achievable almost everywhere. Therefore it is currently the most important task to establish local networks to reach this goal...
  34. ncbi Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Regi
    R Zahn
    Herzzentrum Ludwigshafen
    Herz 25:667-75. 2000
    ..The proportion of transferred patients increased from 1.1% in 1994 to 5.5% in 1998. Contraindications for thrombolysis were the strongest predictor to transfer patients to primary angioplasty...
  35. ncbi Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
    Am J Cardiol 87:1-6. 2001
    ..Thus, the MIR data showed no protective effects of preinfarction angina in patients with AMI treated with primary angioplasty...
  36. ncbi Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Germany
    J Am Coll Cardiol 36:2064-71. 2000
    ..We investigated changes in the clinical outcome of primary angioplasty and thrombolysis for the treatment of acute myocardial infarction (AMI) from 1994 to 1998...
  37. ncbi Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease
    R Zahn
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Blood Coagul Fibrinolysis 13:81-7. 2002
    ..This association was significant only for men. It may indicate a contribution of the APC resistance to the development of CAD, which has to be proven by the follow-up...
  38. ncbi [Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial]
    R Zhan
    Herzzentrum Ludwigshafen, Kardiologie Bremserstrasse 79 67063 Ludwigshafen, Germany
    Z Kardiol 91:49-57. 2002
    ..AMI patients treated with thrombolysis were more likely to be treated with either percutaneous coronary intervention or coronary bypass surgery after discharge...
  39. ncbi Antibiotic therapy after acute myocardial infarction: a prospective randomized study
    Ralf Zahn
    Kardiologie, Herzzentrum Ludwigshafen, Germany
    Circulation 107:1253-9. 2003
    ..We investigated whether treatment with the macrolide antibiotic roxithromycin would reduce mortality or morbidity in patients with an acute myocardial infarction...
  40. ncbi [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry]
    Ralf Zahn
    Herzzentrum, Kardiologie, Ludwigshafen
    Herz 29:181-6. 2004
    ..Under the circumstances of frozen medical budgets in Germany, there may also be a shift toward implantation of a drug-eluting stent (DES) for indications not yet evaluated by RCTs...
  41. ncbi Transcatheter aortic valve implantation: first results from a multi-centre real-world registry
    Ralf Zahn
    Abteilung fur Kardiologie, Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
    Eur Heart J 32:198-204. 2011
    ..We report the first results of the prospective multi-centre German Transcatheter Aortic Valve Interventions-Registry...
  42. ncbi Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study Group
    R Zahn
    Herzzentrum Ludwigshafen, Department of Cardiology, Germany
    J Am Coll Cardiol 35:1820-6. 2000
    ..We describe the baseline characteristics and clinical course of patients who had an acute myocardial infarction (AMI) during their hospital stay...
  43. ncbi Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA)
    Ralf Zahn
    Department of Cardiology, Heart Center Ludwigshafen, Germany
    Herz 28:445-52. 2003
    ..It remains unknown whether the ACT-prolonging effect of abciximab is clinically equivalent to a comparable degree of anti-coagulation by heparin...
  44. ncbi Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center
    R Zahn
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 92:438-44. 2003
    ..Its effectiveness in daily clinical practice in unselected patients remains to be determined...
  45. ncbi Correction of aortic regurgitation after transcatheter aortic valve implantation of the Medtronic CoreValveTM prosthesis due to a too-low implantation, using transcatheter repositioning
    Ralf Zahn
    Kardiologie Pneumologie Angiologie Internistische Intensivmedizin, Herzzentrum Ludwigshafen, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    J Heart Valve Dis 20:64-9. 2011
    ..However, a potential problem of TAVI is the development of severe aortic insufficiency after valve implantation due to a too-low implantation of the valve...
  46. ncbi Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registries
    Ralf Zahn
    Herzzentrum Ludwigshafen, Kardiologie Bremserstrasse 79 67063 Ludwigshafen, Germany
    Z Kardiol 91:64-71. 2002
    ..82, p < 0.0001) in the different subgroups, which showed an increasing absolute benefit of primary angioplasty compared to thrombolysis with increasing mortality risk...
  47. ncbi Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry
    K Donges
    Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
    Am J Cardiol 87:1039-44. 2001
    ..Thrombolysis is associated with a higher and beta blockers with a lower incidence of RE-AMI. Once a RE-AMI occurs, it is a strong predictor of in-hospital mortality and morbidity...
  48. ncbi Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITR
    M Gottwik
    , , Germany
    Eur Heart J 22:1794-801. 2001
    ....
  49. ncbi Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry
    Mohamed Abdel-Wahab
    Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany
    Heart 97:899-906. 2011
    ..Following transcatheter aortic valve implantation (TAVI), AR is common, but little is known about its determinants and its effect on clinical outcome...
  50. ncbi Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial
    U Burkhardt
    , , Bremserstr. 79, 67063 Ludwigshafen, Germany
    Z Kardiol 93:671-8. 2004
    ..pneumoniae and treatment with roxithromycin did not influence these events, independently of the serostatus against C. pneumoniae. However, the power of this subgroup analysis was low to detect small but significant differences...
  51. ncbi Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies
    B Frilling
    Hezzentrum Ludwigshafen, Department of Cardiology, Bremserstr 79, 67063 Ludwigshafen, Germany
    Am Heart J 141:200-5. 2001
    ..However, not all patients receive aspirin for AMI. The aim of this study was to provide information on characteristics and clinical course of patients not treated with aspirin for AMI...
  52. ncbi Incications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)
    U Zeymer
    Herzzentrum Ludwigshafen, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 94:392-8. 2005
    ..The ALKK registry contains about 20% of the invasive and interventional cardiological procedures performed in Germany...
  53. ncbi Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists
    B Mark
    Herzzentrum Ludwigshafen, Kardiologie, Klinikum der Stadt Ludwigshafen, Bremserstrasse 79, 67073 Ludwigshafen, Germany
    Z Kardiol 92:1018-24. 2003
    ..In addition to lesion characteristics, particularly stenting is associated with an increased rate of elevated troponin...
  54. ncbi Two year follow-up in 643 patients with non-invasively unexplained syncope and therapy guided by electrophysiologic study
    K Seidl
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstr 79, 67063 Ludwigshafen, Germany
    Z Kardiol 92:852-61. 2003
    ..Although it has become standard practice to perform electrophysiologic studies in patients with unexplained syncope, limited information exists on prognosis after therapy guided by electrophysiologic studies...
  55. ncbi Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice
    T Heer
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Heart 92:1484-9. 2006
    ..To assess the safety and effectiveness of abciximab in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) in clinical practice...
  56. ncbi Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry)
    Oliver Koeth
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Am J Cardiol 104:1074-7. 2009
    ..Hospital mortality in those patients is very high. Primary PCI improves the prognosis and is therefore the preferred reperfusion strategy in these patients...
  57. ncbi Usefulness of a non-invasive scoring system in predicting the outcome of electrophysiologic studies in non-invasively unexplained syncope
    K Seidl
    Herzzentrum Ludwigshafen, Kardiologie, Bremserstr 79, 67063 Ludwigshafen, Germany
    Z Kardiol 92:147-54. 2003
    ..However, it is invasive with possible procedure-related complications. Therefore, it would be helpful to identify patients in whom an electrophysiologic study is useful for diagnosis of syncope...
  58. ncbi Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Germany
    Thromb Haemost 99:150-4. 2008
    ....
  59. ncbi Gender differences in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock
    Oliver Koeth
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Clin Res Cardiol 98:781-6. 2009
    ..The aim of our analysis is to assess gender differences in baseline characteristics, acute therapies, and clinical outcome in patients with acute ST-elevation myocardial infarction (STEMI) complicated by cardiogenic shock...
  60. ncbi Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Thromb Haemost 99:155-60. 2008
    ..This advantage was associated with an increase in major bleeding complications...
  61. ncbi Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarction
    Timm Bauer
    Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Clin Cardiol 32:718-23. 2009
    ..Little is known about the influence of chronic antithrombotic therapy on treatment and clinical outcome in patients with acute ST-elevation myocardial infarction (STEMI)...
  62. ncbi Coronary aneurysms
    U Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Bremserstrasse 79, 67063 Ludwigshafen, Germany
    Z Kardiol 94:303-4. 2005
  63. ncbi [In-stent-stenosis of a bare-metal stent 11 years after its implantation]
    A C Skarlos
    Herzzentrum, Kardiologie, Klinikum Ludwigshafen
    Dtsch Med Wochenschr 135:1067-70. 2010
    ..A balloon angioplasty of his left anterior descending artery had been performed 12 years ago and two bare-metal stents had been implanted two months later for an early restenosis...
  64. ncbi Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratories
    Patricia Krüth
    Herzzentrum, Med Klinik B, Klinikum Ludwigshafen, Ludwigshafen, Germany
    Clin Res Cardiol 97:742-7. 2008
    ..However little is known about the impact of admission on weekend in hospitals with catheterisation laboratories...
  65. ncbi Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Bremserstrasse 79, Ludwigshafen, Germany
    J Am Coll Cardiol 56:463-9. 2010
    ..The aim of this study was to compare eptifibatide and abciximab as adjuncts to primary percutaneous coronary intervention (PCI)...
  66. ncbi Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction
    Timm Bauer
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    J Cardiovasc Pharmacol 53:132-6. 2009
    ..We sought to investigate the impact of prior statin therapy on in-hospital outcome in patients presenting with acute non-ST-elevation myocardial infarction...
  67. ncbi [Eptifibatide in patients with percutaneous coronary intervention in clinical practice. Results of a prospective registry]
    Uwe Zeymer
    Medizinische Klinik B, Herzzentrum, Ludwigshafen
    Herz 29:651-5. 2004
    ..The aim of the present prospective registry was to evaluate the efficacy and safety of eptifibatide in clinical practice...
  68. ncbi Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study
    Birgit Frilling
    Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
    Am Heart J 148:306-11. 2004
    ..However, a significant number of patients do not receive aspirin after AMI. Little is known about why aspirin is withheld or the long-term outcome of these patients today...
  69. ncbi Angioplasty within 24 h after thrombolysis in patients with acute ST-elevation myocardial infarction: current use, predictors and outcome. Results of the MITRA plus registry
    Oliver Koeth
    Department of Cardiology, Herzzentrum Ludwigshafen, Klinikum Ludwigshafen, Bremserstr 79, 67063 Ludwigshafen am Rhein, Germany
    Clin Res Cardiol 98:107-13. 2009
    ..Percutaneous coronary intervention (PCI) early after thrombolysis (early PCI) in patients with ST-elevation myocardial infarction (STEMI) is currently advised by clinical guidelines, but little is known about its use in clinical practice...
  70. ncbi Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende K
    Uwe Zeymer
    Medizinische Klinik B, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Eur Heart J 25:322-8. 2004
    ..Our results seen in connection with the results of the randomized SHOCK study advocate an early invasive approach in younger patients with cardiogenic shock, while the best strategy in elderly patients is still a matter of debate...
  71. ncbi Clopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarction
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinsche Klinik B, Ludwigshafen, Germany
    Acute Card Care 10:43-8. 2008
    ..We sought to assess the effect of clopidogrel on one-year ischemic events in unselected patients with NSTEMI...
  72. ncbi Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab
    Birgit Frilling
    Heart Center Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany
    Am J Cardiol 89:450-2. 2002
  73. ncbi Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
    Am J Cardiol 98:19-22. 2006
    ....
  74. ncbi Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction
    Timm Bauer
    Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    Eur Heart J 28:2873-8. 2007
    ..We sought to investigate the impact of an invasive treatment in elderly patients presenting with non-ST elevation myocardial infarction (NSTEMI) in clinical practice...
  75. ncbi Evaluation of hospitals regarding outcomes and baseline risk -- an application to percutaneous coronary intervention
    Matthias Hochadel
    Institut für Herzinfarktforschung, Bremserstrasse 79, 67063 Ludwigshafen am Rhein, Germany
    Clin Res Cardiol 96:502-7. 2007
    ..55-5.44%). The outcome of seven centres differed significantly from the expectation. CONCLUSION: In comparisons of the outcome quality of hospitals, adjustment for the patients' baseline risk by an appropriate method is indispensable...
  76. ncbi Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    Eur Heart J 27:2661-6. 2006
    ..We sought to assess the effect of clopidogrel on clinical events 1 year after discharge in survivors of ST-elevation myocardial infarction (STEMI) in clinical practice...
  77. ncbi [Temporal trends in the use of drug-eluting stents in German clinical practice]
    Bärbel Klein
    Medizinische Klinik B, Klinikum der Stadt Ludwigshafen, Herzzentrum, Ludwigshafen
    Herz 33:450-4. 2008
    ..The following study is based on data of the ALKK PCI registry and assesses the use of DES depending on patient characteristics, indication and coronary status comparing the treatment years 2003 and 2005...
  78. ncbi Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial
    Uwe Zeymer
    Herzzentrum Ludwigshafen, Bremserstrasse 79, D 67063 Ludwigshafen, Germany
    Eur Heart J 26:1971-7. 2005
    ..Little is known about the use of eptifibatide in this setting...
  79. ncbi Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice
    Timm Bauer
    Herzzentrum Ludwigshafen, Department of Cardiology, Medizinische Klinik B, Bremserstrasse 79, Ludwigshafen, Germany
    Clin Res Cardiol 98:171-8. 2009
    ..However, it is unclear whether patients treated in interventional facilities with 24-h primary PCI service have lower rates of adverse events...
  80. ncbi A rare manifestation of hypertrophic nonobstructive cardiomyopathy in a young patient without history of cardiac arrhythmias
    Johannes Schwab
    Medizinische Klinik 8, Kardiologie/Angiologie/Internistische Intensivmedizin, , Breslauer Strasse 201, 90471, , Germany
    Clin Res Cardiol 95:357-9. 2006
  81. ncbi Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study
    Karlheinz Seidl
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    J Am Coll Cardiol 39:1436-42. 2002
    ....
  82. ncbi Clinical, angiographic and cardiovascular magnetic resonance findings in consecutive patients with Takotsubo cardiomyopathy
    Oliver Koeth
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Clin Res Cardiol 97:623-7. 2008
    ..The aim was to assess clinical, angiographic and cardiovascular magnetic resonance (CMR) findings in patients with Takotsubo cardiomyopathy...
  83. ncbi Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry)
    Rajendra H Mehta
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 99:1288-93. 2007
    ..This low risk along with the less invasive nature of the procedure should make CAS an attractive and perhaps preferred option for the treatment of these patients...
  84. ncbi Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels
    Rainer Hoffmann
    aMedical Clinic I, University RWTH Aachen, Aachen, Germany
    Coron Artery Dis 18:559-64. 2007
    ..Patients treated with SES for saphenous vein graft disease were compared with patients receiving SES in native vessel disease...
  85. ncbi Drug-eluting stents: effective and safe for every patient and every lesion?
    Uwe Zeymer
    Eur Heart J 28:2559-60. 2007
  86. ncbi Body mass index and effectiveness of reperfusion strategies: implications for the management of patients with ST-elevation myocardial infarction
    Rajendra H Mehta
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Interv Cardiol 21:8-14. 2008
    ..Whether the relatively lower dose results in lower effectiveness of fibrinolytic agents versus primary percutaneous coronary interventions (PCI) in patients with higher body mass index (BMI) is not known...
  87. ncbi Catheter ablation of chronic atrial fibrillation with noncontact mapping: are continuous linear lesions associated with ablation success?
    Karlheinz Seidl
    Department of Clinical Electrophysiology, Division of Cardiology, Heart Center Ludwigshafen, Germany
    Pacing Clin Electrophysiol 26:534-43. 2003
    ..NCM identifies discontinuities in lines of ablation. Successful ablation of chronic AF is associated with continuity of linear lesions and good clinical technique demands a vigilant search for and closure of every gap...